Mitochondrial dysfunction plays a key role in progressive axonal loss in multiple sclerosis

被引:66
作者
Andrews, HE [1 ]
Nichols, PP [1 ]
Bates, D [1 ]
Turnbull, DM [1 ]
机构
[1] Newcastle Univ, Sch Med, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
D O I
10.1016/j.mehy.2004.09.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Multiple Sclerosis is the most common inflammatory demyelinating disease of the central nervous system and is the Leading cause of non traumatic neurological disability in young adults. In recent years it has become increasingly evident that axonal degeneration is a key player in the pathogenesis of disability in MS but the mechanisms that Lead to axonal damage are not fully understood. It seems likely that the causes of axonal damage vary at different stages of the disease and several theories have evolved that address the mechanisms leading to axonal loss in the acute stages of demyelination. There has been relatively little attention given to investigation of the mechanisms involved in chronic axonal, loss in the progressive stages of MS. We propose a hypothesis that mitochondria play a key role in this chronic axonal Loss. Following demyelination there is redistribution of sodium channels along the axon and mitochondria are recruited to the demyelinated regions to meet the increased energy requirements necessary to maintain conduction. The mitochondria present within the chronically demyetinated axons will be functioning at full capacity. The axon may well be able to function for many years due to these adaptive mechanisms but we propose that eventually, despite antioxidant defences, free radical damage will accumulate and mitochondrial function will become compromised. ATP concentration within the axon will decrease and the effect on axonal function will be profound. The actual cause of cell death could be due to a number of mechanisms related to mitochondrial dysfunction including failure of ionic homeostasis, calcium influx, mitochondrial mediated cell death or impaired axonal transport. Whatever the cause of axonal loss our hypothesis is that mitochondria are central to this process. We explore steps to test this hypothesis and discuss the possible therapeutic approaches which target the mitochondrial mechanisms that may contribute to chronic axonal toss. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:669 / 677
页数:9
相关论文
共 62 条
[11]   Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon [J].
Boiko, T ;
Rasband, MN ;
Levinson, SR ;
Caldwell, JH ;
Mandel, G ;
Trimmer, JS ;
Matthews, G .
NEURON, 2001, 30 (01) :91-104
[12]  
Boiko T, 2003, J NEUROSCI, V23, P2306
[13]  
Bolanos JP, 1997, J NEUROCHEM, V68, P2227
[14]   NANOMOLAR CONCENTRATIONS OF NITRIC-OXIDE REVERSIBLY INHIBIT SYNAPTOSOMAL RESPIRATION BY COMPETING WITH OXYGEN AT CYTOCHROME-OXIDASE [J].
BROWN, GC ;
COOPER, CE .
FEBS LETTERS, 1994, 356 (2-3) :295-298
[15]  
BUBIS JJ, 1964, AM J PATHOL, V44, P299
[16]   REVERSIBLE INHIBITION OF CYTOCHROME-C-OXIDASE, THE TERMINAL ENZYME OF THE MITOCHONDRIAL RESPIRATORY-CHAIN, BY NITRIC-OXIDE - IMPLICATIONS FOR NEURODEGENERATIVE DISEASES [J].
CLEETER, MWJ ;
COOPER, JM ;
DARLEYUSMAR, VM ;
MONCADA, S ;
SCHAPIRA, AHV .
FEBS LETTERS, 1994, 345 (01) :50-54
[17]   Benefit of interferon β-1a on MSFC progression in secondary progressive MS [J].
Cohen, JA ;
Cutter, GR ;
Fischer, JS ;
Goodman, AD ;
Heidenreich, FR ;
Kooijmans, MF ;
Sandrock, AW ;
Rudick, RA ;
Simon, JH ;
Simonian, NA ;
Tsao, EC ;
Whitaker, JN .
NEUROLOGY, 2002, 59 (05) :679-687
[18]  
Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO
[19]  
2-#
[20]  
CONDIE RICHARD M., 1959, PROGR NEUROBIOL, V4, P321